Judge: Teva not liable for Oxycontin patent violation

Share this article:

Generics and branded drugmaker Teva took a swing and won against painkiller company Purdue Pharma.

Bloomberg reports that Purdue, whose name is synonymous with Oxycontin, lost a legal battle in which it asserted that Teva's generic violated multiple patents.

US District Judge Sidney Stein agreed that Teva overstepped three patents, but said the “obvious” nature of the patents meant he was not going to hold the company liable.

Purdue told Bloomberg it will appeal the decision.

Share this article:

Email Newsletters

More in Business Briefs

DOJ closes Brilinta investigation

AstraZeneca announced the end of the investigation Tuesday.

Doctors back unique biosimilar names

A host of doctors has asked FDA Commissioner Margaret Hamburg to back a naming convention that would require biologics and biosimilars to have different names.

Roche has no rights to Sovaldi, panel rules

Despite a collaboration with original Sovaldi owner Pharmasset in 2004, a panel ruled Roche has no rights to HCV treatment Sovaldi.